Press Releases (-) Any 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 Reset 2023 May 31, 2023 argenx to Present at Upcoming Investor Conferences May 4, 2023 argenx Reports First Quarter 2023 Financial Results and Provides Business Update May 3, 2023 argenx announces results of Annual General Meeting of Shareholders May 2, 2023 argenx to Present at BofA Securities 2023 Health Care Conference April 27, 2023 argenx to Report First Quarter 2023 Financial Results and Business Update on May 4, 2023 April 18, 2023 argenx Demonstrates Commitment to Redefining Treatment Goals for Generalized Myasthenia Gravis with Multiple Presentations at American Academy of Neurology 2023 Annual Meeting April 17, 2023 argenx and Genmab Enter Partnership to Advance Antibody Therapies in Immunology and Oncology March 17, 2023 argenx Announces Annual General Meeting of Shareholders on May 2, 2023 March 15, 2023 argenx Announces UK MHRA Approval of VYVGART for the Treatment of Generalized Myasthenia Gravis March 2, 2023 argenx Reports Full Year 2022 Financial Results and Provides Fourth Quarter Business Update March 2, 2023 argenx Announces Planned Transition of Chief Operating Officer February 27, 2023 argenx Appoints Steve Krognes to Board of Directors Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
